Dr. Tikva Jacobs, MD

Dr. Jacobs practices at Columbia University Irving Medical Center in New York, New York.

Dr. Jacobs' NPI, 1396711040, was assigned on February 23, 2006. Dr. Jacobs graduated from George Washington University School of Medicine and Health Sciences in 1998. Dr. Jacobs holds New York license 214917.

Dr. Jacobs' primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 305-4920.

Dr. Jacobs' primary practice is Columbia University Irving Medical Center in New York, New York. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Jacobs to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jacobs practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Jacobs' primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Jacobs is board certified in surgery by the American Board of Surgery. Dr. Jacobs is licensed in New York.

Dmand AI lists chronic skin ulcer, deep vein thrombosis (DVT), varicose veins and varicose vein treatment among the conditions Dr. Jacobs treats.

CMS data shows 745 Medicare services from Dr. Jacobs across 8 procedure codes in 2024, for 259 Medicare patients. Medicare paid $123,663 for them. Every service was in an office.

CMS counts 259 Medicare patients who saw Dr. Jacobs in 2024. The largest group is 75 to 84, with 117 patients. 75% of them have high cholesterol, and 65% have arthritis. 18% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Jacobs' median patient age at 56, with 65% women.

In 2024, Dr. Jacobs wrote 18 Medicare Part D claims. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $10,440 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Jacobs for performance year 2024, reported through an alternative payment model (APM). Dr. Jacobs accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 68 procedures of varicose vein removal by Dr. Jacobs, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Jacobs. The most frequent topics are Stents, Aortic Aneurysm, Abdominal and Blood Vessel Prosthesis Implantation. Dr. Jacobs has published most often in J Vasc Surg. Dr. Jacobs' most frequent co-authors are Michael L. Marin, MD, Sharif Ellozy, MD and Larry H. Hollier, MD.

CMS Open Payments shows 5 general payments to Dr. Jacobs from 5 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 100% of the total. W. L. Gore & Associates, Inc. paid the most, $52.

Dr. Jacobs graduated from George Washington University School of Medicine and Health Sciences in 1998.

Dr. Jacobs is in network with 14 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.